Genprex Inc (GNPX) Stock Analysis

Genprex Inc (GNPX) is a publicly traded company in the HEALTHCARE sector. It trades at $0.74, carries a market capitalization of $7.94M. This page summarizes the public market data, fundamentals, and frequently asked questions for GNPX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Genprex Inc currently has a Bullish sentiment score of 0.49.

About Genprex Inc

Genprex, Inc. is a clinical-stage gene therapy company based in Austin, Texas, dedicated to developing groundbreaking therapies aimed at treating cancer and diabetes. Their innovative approach leverages unique gene therapies to address unmet medical needs, with a focus on improving patient outcomes in difficult-to-treat diseases. As a pioneer in the gene therapy space, Genprex is actively advancing its pipeline of therapies through rigorous clinical trials, positioning itself at the forefront...

GNG Research Analysis

GNG Research scores Genprex Inc (GNPX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GNPX.

Frequently Asked Questions

Does GNPX pay dividends?

Genprex Inc (GNPX) does not currently pay a regular dividend.

What is GNPX's market cap?

Genprex Inc (GNPX) has a market capitalization of $7.94M with a current stock price of $0.74.